|
Market Cap | 27.41B | EPS (ttm) | 1.00 |
P/E | 83.14 | EPS this Y | 174.03% |
Forward P/E | 24.84 | EPS next Y | 24.90% |
PEG | 4.16 | EPS past 5Y | 46.35% |
P/S | 8.35 | EPS next 5Y | 20.00% |
P/B | 22.54 | EPS Q/Q | 330.33% |
Dividend | - | Sales Q/Q | 35.73% |
Insider Own | 50.08% | Inst Own | 44.10% |
Insider Trans | -20.23% | Inst Trans | -1.00% |
Short Float | 13.30% | Earnings | May 08/a |
Analyst Recom | 1.91 | Target Price | 74.47 |
Avg Volume | 4.41M | 52W Range | 17.25 - 79.55 |
|
|
Today 07:29AM
|
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
(InvestorPlace) +12.61% |
07:20AM
|
Q1 2024 Applovin Corp Earnings Call
(Thomson Reuters StreetEvents) |
07:15AM
|
Earnings, Catalyst Dearth Curb Wall Street Pre-Bell; Asia, Europe Off
(MT Newswires) |
07:12AM
|
AppLovin Stock Soars As Earnings Top Estimates Amid App Advertising Recovery
(Investopedia) |
06:23AM
|
These Stocks Are Moving the Most Today: Arm, Robinhood, Airbnb, AppLovin, Beyond Meat, SolarEdge, AMC, Duolingo, and More
(Barrons.com) |
03:59AM
|
AppLovin Corp (APP) Q1 2024 Earnings Call Transcript Highlights: Record Revenues and Strategic ...
(GuruFocus.com) |
01:06AM
|
Decoding AppLovin Corp (APP): A Strategic SWOT Insight
(GuruFocus.com) |
May-08-24 09:15PM
|
AppLovin (APP) Q1 2024 Earnings Call Transcript
(Motley Fool) |
07:00PM
|
AppLovin (APP) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
(Zacks) |
06:20PM
|
AppLovin (APP) Tops Q1 Earnings and Revenue Estimates
(Zacks) |
|
AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Valenzuela Victoria | CLO & Corp. Secretary | Apr 04 '24 | Sale | 75.01 | 50,000 | 3,750,500 | 471,560 | Apr 08 05:11 PM | Stumpf Matthew | Chief Financial Officer (CFO) | Mar 14 '24 | Option Exercise | 5.05 | 4,686 | 23,664 | 365,039 | Mar 18 05:23 PM | Chen Herald Y | President & CFO | Mar 14 '24 | Sale | 63.04 | 150,000 | 9,456,604 | 62,418 | Mar 18 05:23 PM | Stumpf Matthew | Chief Financial Officer (CFO) | Mar 14 '24 | Sale | 63.30 | 2,775 | 175,658 | 362,264 | Mar 18 05:23 PM | Vivas Eduardo | Director | Mar 11 '24 | Sale | 60.95 | 1,268 | 77,281 | 8,351,954 | Mar 12 04:24 PM |
|
|
|
|
Market Cap | 667.73M | EPS (ttm) | 5.07 |
P/E | 11.49 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 11.33% |
P/S | 0.58 | EPS next 5Y | - |
P/B | 1.92 | EPS Q/Q | 78.01% |
Dividend | 1.25% | Sales Q/Q | 31.17% |
Insider Own | 4.16% | Inst Own | 81.03% |
Insider Trans | 0.00% | Inst Trans | -3.75% |
Short Float | 0.56% | Earnings | May 08/a |
Analyst Recom | - | Target Price | - |
Avg Volume | 60.96K | 52W Range | 32.48 - 56.17 |
|
|
|
Miller Industries, Inc. (Tennessee) engages in the manufacture of vehicle towing and recovery equipment. Its products include car carriers, light duty, heavy duty, rotators, and special transport. The firm markets its products under the brand names of Century, Challenger, Holmes, Champion, Eagle, Titan, Jige, Boniface, Vulcan, and Chevron. The company was founded by William G. Miller in 1990 and is headquartered in Ooltewah, TN. |
|
|
|
Market Cap | 4.19B | EPS (ttm) | 1.61 |
P/E | 57.62 | EPS this Y | 22.38% |
Forward P/E | 32.63 | EPS next Y | 18.58% |
PEG | 4.97 | EPS past 5Y | 25.47% |
P/S | 13.28 | EPS next 5Y | 11.60% |
P/B | 8.75 | EPS Q/Q | -5.66% |
Dividend | - | Sales Q/Q | 7.93% |
Insider Own | 38.74% | Inst Own | 49.30% |
Insider Trans | 0.00% | Inst Trans | -0.86% |
Short Float | 7.93% | Earnings | May 09/b |
Analyst Recom | 1.14 | Target Price | 93.71 |
Avg Volume | 423.68K | 52W Range | 25.28 - 89.08 |
|
|
|
Camtek Ltd. engages in the business of developing and manufacturing high-end inspection and metrology equipment for the semiconductor industry. The firm is also involved in inspecting integrated circuits and measuring its features on wafers throughout the production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly. The company was founded on October 21, 1987 and is headquartered in Migdal HaEmek, Israel. |
|
| |
|
Market Cap | 1.48B | EPS (ttm) | -4.64 |
P/E | - | EPS this Y | 14.62% |
Forward P/E | - | EPS next Y | 57.48% |
PEG | - | EPS past 5Y | -132.82% |
P/S | 85.03 | EPS next 5Y | - |
P/B | 6.82 | EPS Q/Q | -157.80% |
Dividend | - | Sales Q/Q | 30.76% |
Insider Own | 19.42% | Inst Own | 78.79% |
Insider Trans | -1.38% | Inst Trans | 1.80% |
Short Float | 25.95% | Earnings | May 08/a |
Analyst Recom | 1.33 | Target Price | 54.56 |
Avg Volume | 701.62K | 52W Range | 12.57 - 40.40 |
|
|
|
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Azamian Bobak R. | President/CEO and Board Chair | Mar 18 '24 | Sale | 30.60 | 10,415 | 318,699 | 26,456 | Mar 19 07:05 PM | Neervannan Seshadri | Chief Operating Officer | Mar 18 '24 | Sale | 30.60 | 4,879 | 149,297 | 64,767 | Mar 19 07:03 PM | Mottiwala Aziz | Chief Commercial Officer | Mar 18 '24 | Sale | 30.60 | 4,766 | 145,840 | 54,075 | Mar 19 07:08 PM | Wahl Bryan | General Counsel | Mar 18 '24 | Sale | 30.60 | 4,436 | 135,742 | 40,951 | Mar 19 07:05 PM | Whitfield Dianne C. | Chief Human Resources Officer | Mar 18 '24 | Sale | 30.60 | 4,314 | 132,008 | 34,181 | Mar 19 07:04 PM |
|
|
|
|
Market Cap | 1.49B | EPS (ttm) | -0.43 |
P/E | - | EPS this Y | 191.47% |
Forward P/E | 17.58 | EPS next Y | 87.74% |
PEG | - | EPS past 5Y | - |
P/S | 0.90 | EPS next 5Y | -9.48% |
P/B | 1.85 | EPS Q/Q | 73.26% |
Dividend | 2.92% | Sales Q/Q | 16.85% |
Insider Own | 81.28% | Inst Own | 15.18% |
Insider Trans | 0.00% | Inst Trans | 4.84% |
Short Float | 3.66% | Earnings | May 08/a |
Analyst Recom | 3.67 | Target Price | 9.67 |
Avg Volume | 259.01K | 52W Range | 6.16 - 12.48 |
|
|
|
Kronos Worldwide, Inc. engages in the production and marketing of value-added titanium dioxide pigments. Its products are used for coatings and inks, plastics, paper and paper laminates, man-made fibers, health, food, and beauty, and ceramic, glass, and welding rods applications. The firm also offers assistance in pigment selection, consultation, on-site training, testing on lab scale equipment, and weathering tests technical services. The company was founded in 1916 and is headquartered in Dallas, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hanley Bryan A. | Senior VP and Treasurer | Mar 11 '24 | Buy | 10.65 | 1,000 | 10,652 | 2,500 | Mar 12 08:20 AM | NACE ANDREW B | Executive Vice President | Aug 07 '23 | Buy | 9.17 | 2,728 | 25,000 | 15,453 | Aug 09 10:34 AM | NACE ANDREW B | Executive Vice President | May 24 '23 | Buy | 8.31 | 4,000 | 33,221 | 12,725 | May 24 03:21 PM |
|
|
| |
|
Market Cap | 65.03M | EPS (ttm) | -0.06 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 11.25% |
P/S | 71.46 | EPS next 5Y | 30.00% |
P/B | 18.48 | EPS Q/Q | 41.87% |
Dividend | - | Sales Q/Q | 140.36% |
Insider Own | 17.75% | Inst Own | 6.53% |
Insider Trans | 0.15% | Inst Trans | 0.89% |
Short Float | 1.39% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 3.00 |
Avg Volume | 43.43K | 52W Range | 0.90 - 1.85 |
|
|
|
Research Frontiers, Inc. engages in development, licensing and commercialization of suspended particle device (SPD) light-control technology for automobiles, homes, buildings, aircraft, boats, exhibition and display applications markets. It develops and licenses technologies to other companies that manufactures and markets SPD-smart chemical emulsion or light-control film made from chemical emulsion, lamination services and electronics to power end-products incorporating the film, skylights and sunroofs. The company was founded by Robert L. Saxe in October 1965 and is headquartered in Woodbury, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Daigle Darryl | Director | Feb 07 '24 | Buy | 1.00 | 1,000 | 1,000 | 4,269 | Feb 08 05:50 PM | Daigle Darryl | Director | Dec 11 '23 | Buy | 0.97 | 7,750 | 7,518 | 217,192 | Dec 12 08:45 AM | Daigle Darryl | Director | Oct 02 '23 | Buy | 1.05 | 500 | 525 | 3,269 | Oct 03 09:18 AM | Daigle Darryl | Director | Sep 13 '23 | Buy | 1.40 | 5,350 | 7,490 | 75,158 | Sep 14 02:16 PM | Daigle Darryl | Director | Sep 13 '23 | Buy | 1.35 | 1,600 | 2,160 | 209,442 | Sep 14 02:16 PM |
|
|
|
|
Market Cap | 2.76B | EPS (ttm) | 45.78 |
P/E | 1.99 | EPS this Y | 159.62% |
Forward P/E | 19.35 | EPS next Y | 18.77% |
PEG | 0.11 | EPS past 5Y | 17.07% |
P/S | 0.95 | EPS next 5Y | 18.20% |
P/B | 1.22 | EPS Q/Q | 211.08% |
Dividend | 1.85% | Sales Q/Q | -2.96% |
Insider Own | 3.24% | Inst Own | 101.91% |
Insider Trans | 4.37% | Inst Trans | -6.19% |
Short Float | 6.83% | Earnings | May 09/b |
Analyst Recom | 2.18 | Target Price | 92.79 |
Avg Volume | 339.42K | 52W Range | 65.27 - 89.64 |
|
|
|
Spectrum Brands Holdings, Inc. engages in the manufacture and supply of consumer products and home essentials. The firm operates through the following segments: Home and Personal Care (HPC), Global Pet Care (GPC), and Home and Garden (H&G). The GPC segment focuses on the pet care business. The H&G segment is involved in the home and garden, cleaning products, and insect control business. The HPC segment includes the small kitchen and personal care appliances business. The company was founded in 1906 and is headquartered in Middleton, WI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Maura David M | Executive Chairman and CEO | Nov 28 '23 | Buy | 67.03 | 20,000 | 1,340,600 | 764,391 | Nov 28 04:19 PM | Maura David M | Executive Chairman and CEO | Nov 27 '23 | Buy | 66.41 | 20,000 | 1,328,100 | 744,391 | Nov 28 04:19 PM | Zargar Ehsan | EVP, GC & Corporate Secretary | Nov 27 '23 | Buy | 66.50 | 1,053 | 70,024 | 145,415 | Nov 28 04:21 PM | Maura David M | Executive Chairman and CEO | Aug 29 '23 | Buy | 82.89 | 5,000 | 414,450 | 693,816 | Aug 30 04:30 PM | Zargar Ehsan | EVP, GC & Corporate Secretary | Aug 29 '23 | Buy | 82.98 | 843 | 69,952 | 117,335 | Aug 30 04:31 PM |
|
|
| |
|
Market Cap | 975.55M | EPS (ttm) | -0.30 |
P/E | - | EPS this Y | 229.91% |
Forward P/E | 10.28 | EPS next Y | 0.40% |
PEG | - | EPS past 5Y | 18.91% |
P/S | 2.54 | EPS next 5Y | - |
P/B | 1.06 | EPS Q/Q | -82.94% |
Dividend | 7.19% | Sales Q/Q | -9.02% |
Insider Own | 11.84% | Inst Own | 59.33% |
Insider Trans | -1.22% | Inst Trans | -12.71% |
Short Float | 3.22% | Earnings | May 08/a |
Analyst Recom | 1.67 | Target Price | 24.23 |
Avg Volume | 695.35K | 52W Range | 12.39 - 22.67 |
|
|
|
Genco Shipping & Trading Ltd. is an international ship owning company, which engages in the transportation of iron ore, coal, grain, steel products, and other drybulk cargoes. The company was founded on September 27, 2004 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Adamo Joseph | Chief Accounting Officer | Feb 29 '24 | Option Exercise | 8.35 | 3,413 | 28,485 | 19,867 | Mar 01 07:00 PM | Adamo Joseph | Chief Accounting Officer | Feb 29 '24 | Sale | 20.40 | 1,396 | 28,478 | 17,994 | Mar 01 07:00 PM | WOBENSMITH JOHN C | CEO, President, and Secretary | Feb 23 '24 | Sale | 19.80 | 35,660 | 706,015 | 466,684 | Feb 23 09:17 PM | Christensen Jesper | Chief Commercial Officer | Feb 23 '24 | Sale | 19.80 | 12,404 | 245,636 | 42,587 | Feb 23 09:18 PM | Allen Peter George | Chief Financial Officer | Feb 23 '24 | Sale | 19.80 | 7,036 | 139,283 | 35,518 | Feb 23 09:18 PM |
|
|
|
|
Market Cap | 4.96B | EPS (ttm) | -0.42 |
P/E | - | EPS this Y | 106.39% |
Forward P/E | 39.01 | EPS next Y | 587.18% |
PEG | - | EPS past 5Y | -2.85% |
P/S | 0.76 | EPS next 5Y | - |
P/B | 4.78 | EPS Q/Q | 429.17% |
Dividend | - | Sales Q/Q | 45.77% |
Insider Own | 34.10% | Inst Own | 44.70% |
Insider Trans | -0.87% | Inst Trans | 2.27% |
Short Float | 4.91% | Earnings | May 07/b |
Analyst Recom | 2.00 | Target Price | 19.00 |
Avg Volume | 3.13M | 52W Range | 4.72 - 20.76 |
|
|
|
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Blackley Richard Scott | Chief Financial Officer | Mar 06 '24 | Sale | 14.12 | 27,043 | 381,847 | 614,316 | Mar 07 04:18 PM | Quane Alessandrea C. | EVP, Chief Insurance Officer | Mar 06 '24 | Sale | 14.12 | 13,233 | 186,850 | 212,850 | Mar 07 04:18 PM | Baltrus Victoria | Chief Accounting Officer | Mar 04 '24 | Sale | 15.88 | 33,707 | 535,267 | 118,111 | Mar 05 04:22 PM | Quane Alessandrea C. | EVP, Chief Insurance Officer | Mar 04 '24 | Sale | 15.88 | 15,928 | 252,937 | 194,833 | Mar 05 04:23 PM | Blackley Richard Scott | Chief Financial Officer | Mar 04 '24 | Sale | 15.88 | 14,346 | 227,814 | 578,859 | Mar 05 04:23 PM |
|
|
|
|
Market Cap | 2.21B | EPS (ttm) | -2.82 |
P/E | - | EPS this Y | 111.11% |
Forward P/E | 112.83 | EPS next Y | 625.00% |
PEG | - | EPS past 5Y | - |
P/S | 2.85 | EPS next 5Y | -8.20% |
P/B | 2.92 | EPS Q/Q | 57.02% |
Dividend | - | Sales Q/Q | 11.59% |
Insider Own | 4.29% | Inst Own | 102.30% |
Insider Trans | -0.77% | Inst Trans | 1.69% |
Short Float | 6.39% | Earnings | May 07/a |
Analyst Recom | 2.69 | Target Price | 24.17 |
Avg Volume | 697.38K | 52W Range | 13.82 - 24.21 |
|
|
|
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Riggsbee Richard Bryan | Chief Financial Officer | Dec 01 '23 | Sale | 19.09 | 30,000 | 572,835 | 291,812 | Dec 05 04:19 PM | Riggsbee Richard Bryan | Chief Financial Officer | Nov 01 '23 | Sale | 15.69 | 30,000 | 470,622 | 321,812 | Nov 03 05:12 PM | SPIEGELMAN DANIEL K | Director | Jun 02 '23 | Sale | 23.01 | 8,638 | 198,760 | 40,493 | Jun 02 06:15 PM |
|
|
|